Discussion on “Bayesian meta-analysis of penetrance for cancer risk” by Thanthirige Lakshika M. Ruberu, Danielle Braun, Giovanni Parmigiani, and Swati Biswas
Biometrics · 2024
DOI: 10.1093/biomtc/ujae043 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Biometrics, 2024. Verfasst von Moreno Ursino und 1 weiteren Autor:innen. Beteiligte Einrichtung: Inserm, Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, F-75006, Paris, France. Hauptthemen laut MEDLINE: Bayes Theorem, Meta-Analysis as Topic, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
We congratulate the authors for the new meta-analysis model that accounts for different outcomes. We discuss the modeling choice and the Bayesian setting, specifically, we point out the connection between the Bayesian hierarchical model and a mixed-effect model formulation to subsequently discuss possible future method extensions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inserm, Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, F-75006, Paris, France.
- HeKA, Inria Paris, F-75012 Paris, France.
ORCID-Profile: Moreno Ursino, Sarah Zohar
Zitieren
APA
Ursino, M., & Zohar, S. (2024). Discussion on “Bayesian meta-analysis of penetrance for cancer risk” by Thanthirige Lakshika M. Ruberu, Danielle Braun, Giovanni Parmigiani, and Swati Biswas. Biometrics. https://doi.org/10.1093/biomtc/ujae043
Vancouver
Ursino M, Zohar S. Discussion on “Bayesian meta-analysis of penetrance for cancer risk” by Thanthirige Lakshika M. Ruberu, Danielle Braun, Giovanni Parmigiani, and Swati Biswas. Biometrics. 2024. doi:10.1093/biomtc/ujae043
BibTeX
@article{Ursino2024,
author = {Ursino, Moreno and Zohar, Sarah},
title = {Discussion on “Bayesian meta-analysis of penetrance for cancer risk” by Thanthirige Lakshika M. Ruberu, Danielle Braun, Giovanni Parmigiani, and Swati Biswas},
journal = {Biometrics},
year = {2024},
doi = {10.1093/biomtc/ujae043}
}
EUVIMED